[1] 李昕, 王晴文, 姚树展, 等. 11C-胆碱PET/CT显像在肺癌中的应用价值及其机理的研究[J].医学影像学杂志, 2012, 22(4):546-551. DOI:10.3969/j.issn.1006-9011.2012.04.010.
Li X, Wang QW, Yao SZ, et al. The research of 11C-choline PET/CT imaging and choline metabolism on lung cancer[J]. J Med Imaging, 2012, 22(4):546-551.  doi: 10.3969/j.issn.1006-9011.2012.04.010
[2] Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012[J]. CA Cancer J Clin, 2015, 65(2):87-108. DOI:10.3322/caac.21262.
[3] Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016, 66(2):115-132. DOI:10.3322/caac.21338.
[4] 李培秀, 徐晓磊, 都日娜, 等.恶性孤立性肺结节螺旋CT与PET/CT分析[J].医疗卫生装备, 2016, 37(8):84-86. DOI:10.7687/J.ISSN1003-8868.2016.08.084.
Li PX, Xu XL, Du RN, et al. Spiral CT and PET/CT manifestations of malignant solitary pulmonary nodules[J]. Chin Med Equip J, 2016, 37(8):84-86.  doi: 10.7687/J.ISSN1003-8868.2016.08.084
[5] 林洁, 郑祥武, 殷薇薇, 等. PET/CT双时相显像对孤立性肺结节诊断价值的ROC曲线分析[J].肿瘤学杂志, 2015, 21(4):292-296. DOI:10.11735/j.issn.1671-170X.2015.04.B008.
Lin J, Zheng XW, Yin WW, et al. The ROC analysis of dual time point PET/CT imaging in diagnosis of solitary pulmonary nodule[J]. J Chin Oncol, 2015, 21(4):292-296.  doi: 10.11735/j.issn.1671-170X.2015.04.B008
[6]

Yilmaz F, Tastekin G. Sensitivity of 18F-FDG PET in evaluation of solitary pulmonary nodules[J/OL]. Int J Clin Exp Med, 2015, 8(1):45-51[2017-04-10]. http://www.ncbi.nlm.nih.gov/pubmed/25784973.

[7]

Gould MK, Donington J, Lynch WR, et al. Evaluation of individuals with pulmonary nodules:when is it lung cancer? Diagnosis and management of lung cancer, 3rd ed:American College of Chest Physicians evidence-based clinical practice guidelines[J/OL]. Chest, 2013, 143(5 Suppl):e93S-e120S[2017-04-10]. https://www.ncbi.nlm.nih.gov/pubmed/23649456.DOI:10.1378/chest.12-2351.

[8] Ohno Y, Nishio M, Koyama H, et al. Solitary pulmonary nodules:comparison of dynamic First-Pass contrast-enhanced perfusion Area-Detector CT, dynamic First-Pass contrast-enhanced Mr imaging, and FDG PET/CT[J]. Radiology, 2015, 274(2):563-575. DOI:10.1148/radiol.14132289.
[9] 李文婵, 陈敏, 姚稚明, 等.肺单发结核瘤18F-FDG PET/CT误诊分析[J].中国医学影像学杂志, 2016, 24(10):737-740, 745. DOI:10.3969/j.issn.1005-5185.2016.10.006.
Li WC, Chen M, Yao ZM, et al. Misdiagnosis of 18F-FDG PET/CT in Single Pulmonary Tuberculoma[J]. Chin J Med Imaging, 2016, 24(10):737-740, 745.  doi: 10.3969/j.issn.1005-5185.2016.10.006
[10] 李文婵, 姚稚明, 屈婉莹, 等. SUV小于2.5的孤立性肺结节18F-FDG PET/CT诊断价值初探[J].医学研究杂志, 2011, 40(9):47-51. DOI:10.3969/j.issn.1673-548X.2011.09.016.
Li WC, Yao ZM, Qu WY, et al. 18F-FDG PET/CT characterization of solitary pulmonary nodules with an initial average standard uptake value less than 2.5[J]. J Med Res, 2011, 40(9):47-51.  doi: 10.3969/j.issn.1673-548X.2011.09.016
[11] Schillaci O. Use of dual-point fluorodeoxyglucose imaging to enhance sensitivity and specificity[J]. Semin Nucl Med, 2012, 42(4):267-280. DOI:10.1053/j.semnuclmed.2012.02.003.
[12] 姚稚明, 屈婉莹, 刘甫庚, 等. 18F-FDG PET/CT双时相显像对孤立性肺结节的诊断价值[J].中华核医学杂志, 2007, 27(1):5-7. DOI:10.3760/cma.j.issn.2095-2848.2007.01.002.
Yao ZM, Qu WY, Liu FG, et al. The clinical value of dual time point 18F-FDG PET/CT in diagnosis of solitary pulmonary nodule[J]. Chin J Nucl Med, 2007, 27(1):5-7.  doi: 10.3760/cma.j.issn.2095-2848.2007.01.002
[13] Li Y, Su M, Li F, et al. The value of 18F-FDG-PET/CT in the differential diagnosis of solitary pulmonary nodules in areas with a high incidence of tuberculosis[J]. Ann Nucl Med, 2011, 25(10):804-811. DOI:10.1007/s12149-011-0530-y.
[14] De Wever W, Verschakelen J, Coolen J. Role of imaging in diagnosis, staging and follow-up of lung cancer[J]. Curr Opin Pulm Med, 2014, 20(4):385-392. DOI:10.1097/MCP. 0000000000000066.
[15] Schillaci O. Use of dual-point fluorodeoxyglucose imaging to enhance sensitivity and specificity[J]. Semin Nucl Med, 2012, 42(4):267-280. DOI:10.1053/j.semnuclmed.2012.02.003.
[16] 吴涛, 崔坤炜, 张娟, 等.双时相18F-FDG PET/CT显像对肺部病变良恶性的鉴别诊断价值[J].安徽医学, 2016, 37(11):1393-1396. DOI:10.3969/j.issn.1000-0399.2016.11.021.
Wu T, Cui KW, Zhang J, et al. Diagnostic value of Double-phase 18F-FDG PET/CT in benign and malignant pulmonary lesions[J].Anhui Med J, 2016, 37(11):1393-1396.  doi: 10.3969/j.issn.1000-0399.2016.11.021
[17] 娜仁花, 柴黎明, 居热提·阿扎提, 等. 11C-胆碱PET/CT显像在前列腺癌诊断中对18F-FDG的补充价值[J].中国临床医学影像杂志, 2016, 27(11):799-803. DOI:10.3969/j.issn.1008-1062.2016. 11.011.
Na RH, Chai LM, Jureti AZT, et al. Added value of 11C-choline PET/CT imaging to 18F-FDG PET/CT in primary prostate cancer[J]. J Chin Clin Med Imaging, 2016, 27(11):799-803.  doi: 10.3969/j.issn.1008-1062.2016.11.011
[18] 滕学鹏, 董伟, 刘立恒, 等. PET-CT 11C-胆碱和18F-FDG显像剂联合对肺占位病变鉴别诊断价值分析[J].中华肿瘤防治杂志, 2012, 19(15):1177-1179, 1183.
Teng XP, Dong W, Liu LH, et al. Joint value analysis of 11C-choline and 18F-FDG PET-CT in pulmonary occupying lesions diagnosis[J]. Chin J Cancer Prev Treat, 2012, 19(15):1177-1179, 1183.
[19] 陶鑫, 赵志梅, 刘颖华, 等.孤立性肺结节HRCT征象概率分析的初步研究[J].现代诊断与治疗, 2009, 20(4):196-199. DOI:10.3969/j.issn.1001-8174.2009.04.002.
Tao X, Zhao ZM, Liu YH, et al. Preliminary study on probability analysis of HRCT features of solitary pulmonary nodules[J]. Mod Diagn Treat, 2009, 20(4):196-199.  doi: 10.3969/j.issn.1001-8174.2009.04.002
[20] Jeong SY, Lee KS, Shin KM, et al. Efficacy of PET/CT in the characterization of solid or partly solid solitary pulmonary nodules[J]. Lung Cancer, 2008, 61(2):186-194. DOI:10.1016/j.lungcan.2007.12.021.